NNP
IBB icon

Nachman Norwood & Parrott’s iShares Biotechnology ETF IBB Stock Holding History

Nachman Norwood & Parrott’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-37
Closed -$5K – 611
2020
Q3 		$5K Buy
+37
New +$5.02K ﹤0.01% 957

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Nachman Norwood & Parrott's IBB Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 37 shares — an estimated $5K sold.

Nachman Norwood & Parrott first reported a position in IBB in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 37 iShares Biotechnology ETF shares in Q4 2020, an estimated $5K.
  • Nachman Norwood & Parrott first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's iShares Biotechnology ETF position peaked at $5K in Q3 2020.
  • 856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.